Aptevo Therapeutics Inc. SEC filings APVO

Aptevo Therapeutics Inc. has 740 filings in SEC EDGAR's recent list, going back to Apr 15, 2016. Its latest annual report, Form ARS, was filed on Jul 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.

Aptevo Therapeutics Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Nov 5, 2026 Nov 5, 2026
8-K Current report
Other events
Nov 2, 2026 Oct 30, 2026
424B5 Prospectus supplement Oct 30, 2026 —
8-K Current report
Other events
Oct 26, 2026 Oct 26, 2026
8-K Current report
Material agreement, Change to shareholder rights
Oct 23, 2026 Oct 23, 2026
8-K Current report
Other events
Oct 14, 2026 Oct 14, 2026
S-8 Employee stock plan registration Sep 25, 2026 —
8-K Current report
Other events
Sep 24, 2026 Sep 24, 2026
8-K Current report
Shareholder vote results
Sep 23, 2026 Sep 22, 2026
424B4 Prospectus Sep 3, 2026 —
8-K Current report
Other events
Sep 3, 2026 Sep 3, 2026
EFFECT Filing Sep 2, 2026 —
DEF 14A Proxy statement Aug 31, 2026 Sep 22, 2026
CORRESP Letter to the SEC Aug 31, 2026 —
UPLOAD Letter from the SEC Aug 27, 2026 —
D Filing Aug 26, 2026 —
PRE 14A Preliminary proxy statement Aug 21, 2026 Aug 21, 2026
S-1 Registration statement Aug 21, 2026 —
8-K Current report
Shareholder vote results
Aug 21, 2026 Aug 21, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 13, 2026 Aug 12, 2026
DEF 14A Proxy statement Jul 31, 2026 Jul 31, 2026
ARS Annual report to shareholders Jul 31, 2026 Dec 31, 2025
8-K Current report
Other events
Jul 27, 2026 Jul 27, 2026
S-8 Employee stock plan registration Jul 24, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Jun 30, 2026 Jun 29, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
May 27, 2026 May 25, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
8-K Current report
Other events
May 6, 2026 May 6, 2026
10-K Annual report Mar 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 26, 2026 Mar 26, 2026
8-K Current report
Other events
Mar 11, 2026 Mar 10, 2026
8-K Current report
Shareholder vote results
Feb 19, 2026 Feb 18, 2026
8-K Current report
Officer or director change
Feb 3, 2026 Jan 30, 2026
EFFECT Filing Jan 30, 2026 —
424B4 Prospectus Jan 30, 2026 —
CORRESP Letter to the SEC Jan 29, 2026 —
UPLOAD Letter from the SEC Jan 29, 2026 —
S-1 Registration statement Jan 28, 2026 —
DEF 14A Proxy statement Jan 26, 2026 Jan 23, 2026
PRE 14A Preliminary proxy statement Jan 16, 2026 Jan 16, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 9, 2026 Jan 8, 2026
8-K Current report
Bylaw or fiscal year change
Dec 29, 2025 Dec 29, 2025
8-K Current report Dec 9, 2025 Dec 9, 2025
EFFECT Filing Nov 25, 2025 —
424B4 Prospectus Nov 25, 2025 —
CORRESP Letter to the SEC Nov 24, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Material agreement, Change to shareholder rights
Oct 30, 2025 Oct 30, 2025
S-1 Registration statement Oct 1, 2025 —
8-K Current report
Other events
Sep 16, 2025 Sep 16, 2025
8-K Current report
Other events
Sep 4, 2025 Sep 4, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
424B4 Prospectus Aug 8, 2025 —
EFFECT Filing Aug 1, 2025 —
CORRESP Letter to the SEC Jul 31, 2025 —
UPLOAD Letter from the SEC Jul 30, 2025 —
S-1 Registration statement Jul 25, 2025 —
8-K Current report
Shareholder vote results
Jul 24, 2025 Jul 24, 2025
DEF 14A Proxy statement Jul 3, 2025 Jul 24, 2025
ARS Annual report to shareholders Jul 3, 2025 Jul 3, 2025
8-K Current report
Other events
Jul 1, 2025 Jul 1, 2025
8-K Current report
Other events
Jun 30, 2025 Jun 30, 2025
PRE 14A Preliminary proxy statement Jun 23, 2025 Jul 24, 2025
8-K Current report
Auditor change
Jun 23, 2025 Jun 23, 2025
8-K Current report
Other events
Jun 20, 2025 Jun 20, 2025
424B5 Prospectus supplement Jun 20, 2025 —
8-K Current report
Material agreement, Other events
Jun 20, 2025 Jun 18, 2025
424B4 Prospectus Jun 20, 2025 —
EFFECT Filing Jun 18, 2025 —
S-1MEF Filing Jun 18, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Jun 17, 2025 Jun 16, 2025
CORRESP Letter to the SEC Jun 16, 2025 —
S-1 Registration statement Jun 16, 2025 —
UPLOAD Letter from the SEC Jun 4, 2025 —
DRS Filing May 30, 2025 —
424B3 Prospectus May 28, 2025 —
8-K Current report
Bylaw or fiscal year change
May 23, 2025 May 23, 2025
EFFECT Filing May 22, 2025 —
8-K Current report
Listing notice, Other events
May 22, 2025 May 22, 2025
424B5 Prospectus supplement May 22, 2025 —
CORRESP Letter to the SEC May 21, 2025 —
UPLOAD Letter from the SEC May 20, 2025 —
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
S-1 Registration statement May 13, 2025 —
RW Filing May 13, 2025 —
RW Filing May 13, 2025 —
S-3 Shelf registration May 2, 2025 —
8-K Current report
Other events
Apr 29, 2025 Apr 29, 2025
424B5 Prospectus supplement Apr 29, 2025 —
424B4 Prospectus Apr 28, 2025 —
8-K Current report
Material agreement, Results of operations, Other events
Apr 28, 2025 Apr 28, 2025
DEF 14A Proxy statement Apr 25, 2025 May 14, 2025
8-K Current report
Material agreement, Other events
Apr 22, 2025 Apr 21, 2025
424B4 Prospectus Apr 22, 2025 —
D Filing Apr 18, 2025 —
PRE 14A Preliminary proxy statement Apr 10, 2025 May 9, 2025
8-K Current report
Material agreement, Other events
Apr 4, 2025 Apr 3, 2025
424B4 Prospectus Apr 4, 2025 —
S-1/A Amended registration statement Apr 1, 2025 —
S-1/A Amended registration statement Mar 27, 2025 —
S-1/A Amended registration statement Mar 27, 2025 —
S-1/A Amended registration statement Mar 25, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Mar 20, 2025 Mar 20, 2025
S-1 Registration statement Mar 3, 2025 —
EFFECT Filing Feb 26, 2025 —
CORRESP Letter to the SEC Feb 24, 2025 —
UPLOAD Letter from the SEC Feb 21, 2025 —
S-3 Shelf registration Feb 14, 2025 —
10-K Annual report Feb 14, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 14, 2025 Feb 14, 2025
8-K Current report
Regulation FD disclosure
Feb 11, 2025 Feb 11, 2025
EFFECT Filing Jan 2, 2025 —
CORRESP Letter to the SEC Jan 2, 2025 —
UPLOAD Letter from the SEC Dec 30, 2024 —
S-3 Shelf registration Dec 20, 2024 —
8-K Current report
Material agreement, Unregistered share sale
Dec 12, 2024 Dec 12, 2024
8-K Current report
Other events
Dec 12, 2024 Dec 12, 2024
8-K Current report
Other events
Dec 4, 2024 Dec 4, 2024
8-K Current report
Bylaw or fiscal year change
Dec 3, 2024 Dec 3, 2024
8-K Current report
Other events
Nov 26, 2024 Nov 26, 2024
8-K Current report
Other events
Nov 22, 2024 Nov 22, 2024
8-K Current report
Other events
Nov 20, 2024 Nov 20, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Material agreement, Change to shareholder rights
Nov 4, 2024 Nov 1, 2024
8-K Current report
Shareholder vote results
Oct 25, 2024 Oct 25, 2024
DEF 14A Proxy statement Oct 3, 2024 Oct 25, 2024
PRE 14A Preliminary proxy statement Sep 23, 2024 Oct 25, 2024
8-K Current report
Material agreement, Other events
Sep 18, 2024 Sep 16, 2024
424B4 Prospectus Sep 17, 2024 —
EFFECT Filing Sep 16, 2024 —
8-K Current report
Other events
Sep 16, 2024 Sep 16, 2024
CORRESP Letter to the SEC Sep 11, 2024 —
CORRESP Letter to the SEC Sep 11, 2024 —
UPLOAD Letter from the SEC Sep 6, 2024 —
S-1 Registration statement Aug 30, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Shareholder vote results
Aug 7, 2024 Aug 6, 2024
DEF 14A Proxy statement Jul 15, 2024 Aug 6, 2024
S-8 Employee stock plan registration Jul 12, 2024 —
PRE 14A Preliminary proxy statement Jul 3, 2024 Dec 31, 2024
8-K Current report
Listing notice
Jul 1, 2024 Jun 25, 2024
8-K Current report
Material agreement, Other events
Jul 1, 2024 Jun 28, 2024
EFFECT Filing Jun 28, 2024 —
424B4 Prospectus Jun 28, 2024 —
S-1/A Amended registration statement Jun 26, 2024 —
CORRESP Letter to the SEC Jun 25, 2024 —
UPLOAD Letter from the SEC Jun 20, 2024 —
S-1 Registration statement Jun 14, 2024 —
8-K Current report
Shareholder vote results
Jun 10, 2024 Jun 7, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Apr 23, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 23, 2024 —
DEF 14A Proxy statement Apr 23, 2024 Dec 31, 2023
8-K Current report
Material agreement, Other events
Apr 15, 2024 Apr 10, 2024
424B4 Prospectus Apr 12, 2024 —
EFFECT Filing Apr 10, 2024 —
S-1/A Amended registration statement Apr 9, 2024 —
CORRESP Letter to the SEC Apr 8, 2024 —
CORRESP Letter to the SEC Apr 8, 2024 —
CORRESP Letter to the SEC Mar 29, 2024 —
S-1/A Amended registration statement Mar 29, 2024 —
UPLOAD Letter from the SEC Mar 29, 2024 —
S-1 Registration statement Mar 20, 2024 —
8-K Current report
Other events
Mar 7, 2024 Mar 7, 2024
8-K Current report
Bylaw or fiscal year change
Mar 5, 2024 Mar 5, 2024
10-K Annual report Mar 5, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 5, 2024 Mar 5, 2024
8-K Current report
Shareholder vote results
Feb 6, 2024 Feb 5, 2024
DEFR14A Filing Jan 30, 2024 —
DEFR14A Filing Jan 16, 2024 —
DEF 14A Proxy statement Dec 22, 2023 Dec 22, 2023
PRE 14A Preliminary proxy statement Dec 12, 2023 Dec 13, 2023
EFFECT Filing Nov 30, 2023 —
CORRESP Letter to the SEC Nov 29, 2023 —
UPLOAD Letter from the SEC Nov 29, 2023 —
S-3 Shelf registration Nov 22, 2023 —
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
8-K Current report
Material agreement, Unregistered share sale
Nov 9, 2023 Nov 9, 2023
8-K Current report
Material agreement, Change to shareholder rights
Nov 3, 2023 Nov 2, 2023
8-K Current report
Listing notice
Sep 15, 2023 Sep 13, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Material agreement, Other events
Aug 7, 2023 Aug 1, 2023
424B4 Prospectus Aug 3, 2023 —
EFFECT Filing Aug 1, 2023 —
S-1/A Amended registration statement Aug 1, 2023 —
CORRESP Letter to the SEC Aug 1, 2023 —
CORRESP Letter to the SEC Aug 1, 2023 —
CORRESP Letter to the SEC Jul 28, 2023 —
CORRESP Letter to the SEC Jul 28, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
APVO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Seattle, WA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1671584

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.